AU2002328596A1 - Diamine derivatives - Google Patents

Diamine derivatives

Info

Publication number
AU2002328596A1
AU2002328596A1 AU2002328596A AU2002328596A AU2002328596A1 AU 2002328596 A1 AU2002328596 A1 AU 2002328596A1 AU 2002328596 A AU2002328596 A AU 2002328596A AU 2002328596 A AU2002328596 A AU 2002328596A AU 2002328596 A1 AU2002328596 A1 AU 2002328596A1
Authority
AU
Australia
Prior art keywords
diamine derivatives
diamine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002328596A
Other versions
AU2002328596B2 (en
Inventor
Noriyasu Haginoya
Hideyuki Kanno
Syozo Kobayashi
Satoshi Komoriya
Akiyoshi Mochizuki
Masatoshi Nagamochi
Tsutomu Nagata
Hiroyuki Naito
Yumi Nakamoto
Toshiharu Ohta
Makoto Ono
Kouichi Uoto
Kenji Yoshikawa
Toshiharu Yoshino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2002/002683 external-priority patent/WO2003000657A1/en
Priority claimed from PCT/JP2002/006141 external-priority patent/WO2003000680A1/en
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority claimed from PCT/JP2002/008119 external-priority patent/WO2003016302A1/en
Publication of AU2002328596A1 publication Critical patent/AU2002328596A1/en
Application granted granted Critical
Publication of AU2002328596B2 publication Critical patent/AU2002328596B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002328596A 2001-08-09 2002-08-08 Diamine derivatives Ceased AU2002328596B2 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
JP2001-243046 2001-08-09
JP2001243046 2001-08-09
JP2001311808 2001-10-09
JP2001-311808 2001-10-09
JP2001398708 2001-12-28
JP2001-398708 2001-12-28
PCT/JP2002/002683 WO2003000657A1 (en) 2001-06-20 2002-03-20 Diamine derivatives
AU2002242954 2002-03-20
AUPCT/JP2002/006141 2002-06-20
PCT/JP2002/006141 WO2003000680A1 (en) 2001-06-20 2002-06-20 Diamine derivatives
PCT/JP2002/008119 WO2003016302A1 (en) 2001-08-09 2002-08-08 Diamine derivatives

Publications (2)

Publication Number Publication Date
AU2002328596A1 true AU2002328596A1 (en) 2003-05-29
AU2002328596B2 AU2002328596B2 (en) 2007-09-20

Family

ID=32600712

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002328596A Ceased AU2002328596B2 (en) 2001-08-09 2002-08-08 Diamine derivatives

Country Status (16)

Country Link
EP (1) EP1415992B1 (en)
JP (1) JP4331595B2 (en)
KR (1) KR100908966B1 (en)
CN (1) CN100545160C (en)
AT (1) ATE556066T1 (en)
AU (1) AU2002328596B2 (en)
BR (1) BR0211565A (en)
CA (1) CA2456841A1 (en)
ES (1) ES2383749T3 (en)
HK (1) HK1095814A1 (en)
IL (2) IL160204A0 (en)
MX (1) MXPA04001272A (en)
NO (1) NO327003B1 (en)
PL (1) PL368402A1 (en)
RU (1) RU2314303C2 (en)
WO (1) WO2003016302A1 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI288745B (en) 2000-04-05 2007-10-21 Daiichi Seiyaku Co Ethylenediamine derivatives
CA2451605C (en) * 2001-06-20 2010-08-10 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
US7365205B2 (en) 2001-06-20 2008-04-29 Daiichi Sankyo Company, Limited Diamine derivatives
AU2003292828B9 (en) * 2002-12-25 2009-10-01 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
US7291615B2 (en) 2003-05-01 2007-11-06 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
US7378409B2 (en) 2003-08-21 2008-05-27 Bristol-Myers Squibb Company Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
KR101215153B1 (en) 2003-11-12 2012-12-24 다이이찌 산쿄 가부시키가이샤 Process for producing thiazole derivative
CZ2006427A3 (en) 2003-12-29 2006-11-15 Sepracor Inc. Pyrrole and pyrazole DAAO inhibitors
HUE029336T2 (en) * 2005-09-16 2017-02-28 Daiichi Sankyo Co Ltd Optically active diamine derivative and process for producing the same
AU2006335174B2 (en) 2006-01-06 2012-09-06 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
AU2007205114B2 (en) 2006-01-06 2012-11-08 Sunovion Pharmaceuticals Inc. Cycloalkylamines as monoamine reuptake inhibitors
AU2007233041B2 (en) 2006-03-31 2013-05-02 Sepracor Inc. Preparation of chiral amides and amines
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
JP5187901B2 (en) 2006-08-30 2013-04-24 塩野義製薬株式会社 Hydrazine amide derivatives
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
CN101652139A (en) 2007-03-29 2010-02-17 第一三共株式会社 Pharmaceutical composition
EP3296289A3 (en) 2007-05-31 2018-06-20 Sunovion Pharmaceuticals Inc. Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
CA2746570A1 (en) 2008-12-12 2010-06-17 Daiichi Sankyo Company, Limited Process for producing optically active carboxylic acid
WO2010071121A1 (en) * 2008-12-17 2010-06-24 第一三共株式会社 Method for producing diamine derivative
JPWO2010082531A1 (en) 2009-01-13 2012-07-05 第一三共株式会社 Activated blood coagulation factor inhibitor
JP5666424B2 (en) 2009-03-10 2015-02-12 第一三共株式会社 Method for producing diamine derivative
EP2407450B1 (en) 2009-03-13 2015-04-22 Daiichi Sankyo Company, Limited Method for producing optically active diamine derivative
WO2010131663A1 (en) * 2009-05-15 2010-11-18 第一三共株式会社 Oxamide derivative
ES2605034T3 (en) 2009-06-18 2017-03-10 Daiichi Sankyo Company, Limited Pharmaceutical composition with improved solubility
WO2011059080A1 (en) * 2009-11-16 2011-05-19 第一三共株式会社 Isotope-substituted diamine derivative
JP5714562B2 (en) 2010-02-22 2015-05-07 第一三共株式会社 Oral sustained-release solid preparation
ES2706880T3 (en) 2010-02-22 2019-04-01 Daiichi Sankyo Co Ltd Sustained-release solid preparation for oral use
EP2540317A4 (en) 2010-02-22 2014-04-16 Daiichi Sankyo Co Ltd Sustained-release solid preparation for oral use
JP5692873B2 (en) 2010-03-19 2015-04-01 第一三共株式会社 Crystal of diamine derivative and method for producing the same
WO2011115067A1 (en) 2010-03-19 2011-09-22 第一三共株式会社 Method for improving dissolvability of anticoagulant
WO2011149110A1 (en) 2010-05-28 2011-12-01 Daiichi Sankyo Company, Limited Novel composition for the prevention and/or treatment of thromboembolism
CN103080078B (en) 2010-07-02 2015-02-11 第一三共株式会社 Process for preparation of optically active diamine derivative salt
CN103140466B (en) 2010-08-04 2016-02-17 第一三共株式会社 Compound oxygen radical of nitrogen is adopted to prepare the method for compound through the reaction of new sandmeyer type as catalysts
WO2013022059A1 (en) 2011-08-10 2013-02-14 第一三共株式会社 Pharmaceutical composition containing diamine derivative
EP2893928B1 (en) 2012-09-03 2018-10-24 Daiichi Sankyo Company, Limited Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition
WO2014157612A1 (en) 2013-03-29 2014-10-02 第一三共株式会社 Method for producing (1s,4s,5s)-4-bromo-6- oxabicyclo[3.2.1]octane-7-one
TWI602803B (en) 2013-03-29 2017-10-21 第一三共股份有限公司 Preparation method of optically active diamine compound
CA2940001C (en) * 2014-02-18 2019-01-15 Daiichi Sankyo Company, Limited Method for producing inhibitor of activated blood coagulation factor x (fxa)
JP2017210468A (en) * 2016-05-23 2017-11-30 宇部興産株式会社 Method of producing iodolactone compound
JP6696474B2 (en) * 2016-06-24 2020-05-20 宇部興産株式会社 Method for producing oxabicyclooctane compound
CN106467475A (en) * 2016-08-29 2017-03-01 上海大学 The preparation method of ortho position double azido compound
CN107573256B (en) * 2017-09-26 2020-02-21 安徽国星生物化学有限公司 Continuous production method and device for p-chlorophenylhydrazine hydrochloride
WO2020094008A1 (en) * 2018-11-06 2020-05-14 天津药物研究院有限公司 2-oxo-1,2-dihydroquinoline derivatives, preparation method therefor, and pharmaceutical applications thereof
CN111606827B (en) * 2020-06-23 2022-10-25 内蒙古京东药业有限公司 Method for preparing chiral amine intermediate of edoxaban
CN111763222B (en) * 2020-08-03 2021-05-25 珠海市海瑞德新材料科技有限公司 Intermediate for preparing edoxaban free base and preparation method and application thereof
WO2022129535A1 (en) 2020-12-18 2022-06-23 Krka, D.D., Novo Mesto Edoxaban formulation containing no sugar alcohols

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0224566A1 (en) * 1985-06-07 1987-06-10 The Upjohn Company Antiarrhythmic use for aminocycloalkylamides
WO1992004017A1 (en) * 1990-09-10 1992-03-19 The Upjohn Company Cis-n-(2-aminocyclohexyl)benzamide and their enantiomers as anticonvulsants
US5430150A (en) * 1992-12-16 1995-07-04 American Cyanamid Company Retroviral protease inhibitors
CA2157412A1 (en) * 1993-03-03 1994-09-15 Julia Marie Heerding Balanoids
DE19536783A1 (en) 1995-09-21 1997-03-27 Diagnostikforschung Inst Bifunctional nicotinamide chelating agents of the type N¶2¶S¶2¶ for radioactive isotopes
US6274715B1 (en) 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
IT1291823B1 (en) * 1997-04-08 1999-01-21 Menarini Ricerche Spa PSEUDO-PEPTIDE COMPOUNDS, THEIR PREPARATION AND USE IN PHARMACEUTICAL FORMULATIONS
US6207679B1 (en) * 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6130349A (en) * 1997-12-19 2000-10-10 The Board Of Trustees Of The Leland Stanford Junior University Catalytic compositions and methods for asymmetric allylic alkylation
DE19814801A1 (en) * 1998-04-02 1999-10-07 Basf Ag Process for the preparation of 1,3,4-trisubstituted 1,2,4-triazolium salts
GB9807104D0 (en) * 1998-04-02 1998-06-03 Chirotech Technology Ltd The preparation of phosphine ligands
WO1999054308A1 (en) * 1998-04-21 1999-10-28 Du Pont Pharmaceuticals Company 5-aminoindeno(1,2-c)pyrazol-4-ones as anti-cancer and anti-proliferative agents
AU4631499A (en) * 1998-06-30 2000-01-17 Chirotech Technology Limited The preparation of arylphosphines
TW434207B (en) * 1998-07-24 2001-05-16 Everlight Chem Ind Corp Chiral ligand and method for preparing cyanohydrins from aldehydes
US6747023B1 (en) * 1998-08-11 2004-06-08 Daiichi Pharmaceutical Co., Ltd. Sulfonyl derivatives
AU2241400A (en) * 1999-04-06 2000-10-12 Yamanouchi Pharmaceutical Co., Ltd. Novel thiazolobenzoimidazole derivative
GB9909592D0 (en) * 1999-04-26 1999-06-23 Chirotech Technology Ltd Process for the preparation of calanolide precursors
JP2003502296A (en) * 1999-06-15 2003-01-21 ロディア・シミ Sulfonylamides and carboxamides and their use in asymmetric catalysis
US6492408B1 (en) * 1999-07-21 2002-12-10 Boehringer Ingelheim Pharmaceuticals, Inc. Small molecules useful in the treatment of inflammatory disease
TWI288745B (en) * 2000-04-05 2007-10-21 Daiichi Seiyaku Co Ethylenediamine derivatives
US7365205B2 (en) * 2001-06-20 2008-04-29 Daiichi Sankyo Company, Limited Diamine derivatives
CA2451605C (en) * 2001-06-20 2010-08-10 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
ATE439360T1 (en) * 2001-09-21 2009-08-15 Bristol Myers Squibb Co LACTAM-CONTAINING COMPOUNDS AND THEIR DERIVATIVES AS FACTOR XA INHIBITORS
AU2002350217A1 (en) * 2001-12-04 2003-06-17 Bristol-Myers Squibb Company Glycinamides as factor xa inhibitors
EP1505966A4 (en) * 2002-05-10 2006-08-30 Bristol Myers Squibb Co 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors

Similar Documents

Publication Publication Date Title
AU2002346300A1 (en) Diamine derivatives
AU2002328596A1 (en) Diamine derivatives
HK1092461A1 (en) Diamine derivatives
IL159438A0 (en) Diamine derivatives
AU2002349676A1 (en) 4-oxoquinoline derivatives
HK1068608A1 (en) 3-Substituted-4-pyrimidone derivatives
HK1068607A1 (en) Phenylalkyloxy-phenyl derivatives
HUP0303186A3 (en) 4-aminobenzopyran derivatives
HUP0401949A3 (en) 4-imidazolin-2-one derivatives
HUP0500026A3 (en) N-heteroarylnicotinamide derivatives
AU2002363600A1 (en) Novel phenyl-propargylether derivatives
EP1364954A4 (en) Dicarba-closo-dodecarborane derivatives
AU2002332178A1 (en) Benzimidazole derivatives
AU2002358715A1 (en) Tetrahydrobenzfluorene derivatives
AU2002242954A1 (en) Diamine derivatives
AU2002255269B8 (en) 2-Iminopyrrolidine derivatives
AU2002249205A1 (en) Bis-triazinylaminobenzoxazole derivatives
AU2002230196A1 (en) Dicarba-closo-dodecarborane derivatives
AU2002255269A1 (en) 2-Iminopyrrolidine derivatives
AU2002325368A1 (en) Benzoylcyclohexenone derivatives
AU2002305184A1 (en) Cycloalkenylsulfonamide derivatives
AU2002253080A1 (en) Biurethane derivatives
AU2002302578A1 (en) Amido-diphenyl derivatives
AU2002350425A1 (en) 6-phenyldihydropyrrolopyrimidinedione derivatives
AU2002354530A1 (en) 4-phenylpyran-2-one derivatives